The European Respiratory Society (ERS) works with policymakers and in collaboration with civil society organisations to improve early recognition and early diagnosis of chronic diseases. We advocate for cost-effective screening methods as well as promote innovative approaches to chronic care, such as ehealth and mhealth. ERS lobbies for EU funding for long-term and industry-independent trials that involve patients with non-communicable diseases.
of people with bronchiectasis have an existing condition, such as cystic fibrosis or an immune deficiency.
Europeans aged under 45 have asthma.
of cystic fibrosis patients are over 18 years old and this proportion is growing.